Japan Society of Chemotherapy

Recent papers from Japan Society of Chemotherapy

1. A Pragmatic Approach to Investigating Nosocomial Acquisition of Rare and Emerging MoldsMedical Mycology · 2026
2. Hierarchical Collagen Nanofiber Gels Recapitulate a Physiologically Relevant Tumor Stromal MicroenvironmentAdvanced Healthcare Materials · 2026
3. PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencingOncology Reviews · 2026
4. Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case reportFrontiers in Oncology · 2026
5. Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr ‐mutated lung cancerMolecular Oncology · 2026
6. Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective studyScientific Reports · 2026
7. Management of Gastric Cancer Peritoneal Metastasis: IGCA Working Group Consensus StatementsBritish journal of surgery · 2026
8. Concerted pH‐Responsive Performance of Chitosan–Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell DisruptionChemMedChem · 2026
9. Immunological profile of the tumor immune microenvironment of upper tract urothelial carcinoma predicts recurrence patternsCancer Immunology Immunotherapy · 2026
10. Phase 1/2 trial of brigatinib plus panitumumab in patients with osimertinib-resistant EGFR-mutated non-small cell lung cancer harboring EGFR C797S mutationCancer Treatment and Research Communications · 2026
11. Engineering a multilayered 3D stromal barrier model for quantitative analysis of T cell infiltration and cytotoxicityActa Biomaterialia · 2025
12. Plasma cfDNA analysis of alectinib resistance-related gene alterations in the J-ALEX studyESMO Open · 2025
13. Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastomaCell Death Discovery · 2025
14. Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasisGastric Cancer · 2025
15. Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinomaBMC Cancer · 2025
16. Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localizationnpj Precision Oncology · 2025
17. The Hippo Signaling Pathway Manipulates Cellular SenescenceCells · 2024
18. Gemcitabine-Based Chemotherapy for Advanced Soft Tissue Sarcoma: Identifying the Appropriate Dose and ScheduleCureus · 2024
19. Japanese guidelines for treatment of pediatric status epilepticus – 2023Brain and Development · 2024
20. Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancernpj Precision Oncology · 2024